Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
NAPLES, Fla., May 16, 2017 -- HealthLynked Corp. (OTCQB:HLYK) yesterday announced its first quarter 2017 financial results. The Company reported revenue of $476,118, and an operating loss of $387,490 that included approximately $117,000 of legal, accounting and other expenses related to our initial public filings. These results compare with revenue of $513,567 and operating loss of $147,238 in the first quarter of 2016.
Dr. Michael Dent, Chairman and Chief Executive Officer stated, “We continue to invest in the HealthLynked Network and our software development, which is scheduled for release next month. To that end, we commenced trading on the OTCQB on May 10th under the symbol ‘HLYK.’ The SEC declared our S1 filing related to our $3M Investment Agreement effective as of 5pm May 15, 2017. We have also raised $395,000 this year through sale of our common stock. We are very excited to launch the HealthLynked Network and execute on our goal of integrating healthcare.”
About HealthLynked Corp.
HealthLynked Corp. provides a solution for both patient members and healthcare providers to improve healthcare. The HealthLynked Network is a cloud-based platform that allows patients to enter their medical history, medications, allergies, past surgeries and medical records in one convenient online secure location, free of charge.
Participating healthcare providers realize benefits in the ability to see more patients, access more accurate patient information, participate in our telemedicine program, improve patient retention and increase online filing of vacancies including last minute cancellations through our “real time appointment scheduling” mobile application. Healthcare providers pay a monthly fee to increase online visibility, recruit new patients, and improve office efficiency.
For additional information about HealthLynked Corp. visit www.healthlynked.com.
Forward Looking Statements
Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements. These forward looking statements involve a number of risks and uncertainties that could cause actual future results to differ materially from those anticipated in the forward looking statements, Actual results could differ materially from such statements expressed or implied herein. Factors that might cause such a difference include, among others, the company's ability to gain new customers, offer new types of services, and otherwise implement its business plan. As a result, this press release should be read in conjunction with the company's filings with the SEC.
Company Contact: George O’Leary Chief Financial Officer [email protected] Investor Relations contact: Amato and Partners, LLC Investor Relations Counsel [email protected]
